Skip to main content
OpenTrials
Completed

NCT Number: NCT06028776

Effects of MS Ballroom Fitness on Balance, Walking Capacity, and Well-being in Multiple Sclerosis

The goal of the present study is to evaluate the effects of a dance-based concept entitled MS Ballroom Fitness (developed in Denmark by PT Elisabeth Dalsgaard) in persons with multiple sclerosis (pwMS). A total of 88 pwMS will be enrolled and equally randomized into an intervention group or a control-waitlist group. Those in the intervention group will undertake 7 weeks of MS Ballroom Fitness, with 2 sessions per week.

The investigators assume that balance, walking capacity as well as well-being will be improved.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Aarhus University, Exercise Biology

Aarhus C, Jutland, 8000, Denmark

About this study

Multiple sclerosis (MS) is a chronic inflammatory and neurodegenerative disease of the central nervous system (CNS) causing demyelination of axons within the CNS as well as loss of axons and neurons. While a wide range of symptoms potentially develops due to the pathology of MS, lower extremity motor function appears preferentially affected. It is therefore not surprising that substantial impairments in balance and walking capacity have been reported in pwMS, based on both subjective (patient perspectives) and objective assessments. This is problematic as balance and walking capacity are rated among the most important bodily functions, and furthermore associated with mental well-being and quality of life.

In pwMS, walking balance/coordination can be assessed by the six spot step test (SSST). Dynamic balance/coordination can be assessed by the four sqaure step test (FSST). Balance can also be assessed by the functional reach test (FRT) as well as the 30-second single leg stance test. Other measures of walking capacity can be assessed by a 'simple' short distance walk test (e.g., the timed 25 foot maximal walk test (T25FWT)) and a long distance 'endurance' walk test (e.g., the 6-minute maximal walk test (6MWT)). In addition to these, the 12-item MS Walking Scale (MSWS-12) are commonly used to assess the patient-reported impact of MS on different aspects of walking ability.

Different modalities of exercise therapy have been shown effective in counteracting the deterioration of balance and walking capacity observed in pwMS, with improvements reported across all the tests outlined above. Interestingly, dance (including mixed modalities with a predominant dance-based content) appear particularly potent in terms of targeting impairments in balance AND walking capacity. Whilst some pilot/exploratory studies involving pwMS exist, the summarized evidence appear sparse and contain three major limitations. First, the majority of pwMS studies are small exploratory non-controlled studies lacking sample size calculations. Second, none of the identified dance studies provide a personalized approach, i.e., by designing interventions that embrace the needs and physical functional level of each participant. Third, none of the identified dance studies have assessed whether dance-induced adaptations in balance and walking capacity are accompanied by - or even translates into - improvements in mental well-being and quality of life.

Physiotherapist Elisabeth Dalsgaard has developed a dance-based concept entitled MS Ballroom FitnessTM (abbreviated MSB-Fit) with a specific focus on joy of life and inclusion. It is specifically adapted to pwMS, having three difficulty levels that correspond to three overall disability categories (sitting, standing, and walking pwMS).

The study sample size was calculated based on unpublished SSST pilot data from n=11 pwMS undergoing 7 weeks of MSB-Fit, corresponding to what was offered in the present study. The estimate (α = 0.05; power = 0.90; control mean post intervention 7.16±1.18 s; MSB-Fit mean post intervention 6.27±1.18 s; dropout rate = 15%) suggested that a total of n=88 pwMS should be enrolled in the present study.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • self-reported MS diagnosis
  • patient-determined disease steps (PDDS) ≤ 7 (7 correspond to use a wheelchair for most daily activities)
  • able to independently attend the testing

Exclusion criteria

  • self-reported comorbidities excluding participation in the intervention
  • substantial cognitive impairments hindering participation
  • recent fractures (6 months)
  • critical physical impairments hindering participation in the described training study
  • participation in structured exercise therapy (including dancing) for the past 3 months (≥ 2 session per week of moderate-to-high intensity)

Treatment and study plan

MS Ballroom Fitness

Behavioral

A personalized dance-based concept focusing on balance, walking capacity, and well-being.

Primary outcomes

  1. Six spot step test (SSST)

    Time frame: Change from Baseline to 7 weeks

    Objective test that measures walking coordination and balance. Unit: seconds.

  2. WHO5 wellbeing index

    Time frame: Change from Baseline to 7 weeks

    Questionnaire that measures current mental well-being. Unit: score (0-100; 100 is better).

Secondary outcomes

  1. Static balance

    Time frame: Change from Baseline to 7 weeks

    Objective test that measures static balance (total score based on 2 different tests; 20s right leg foot stand, 20s left leg foot stand). Unit: seconds (0-40s; 40s is better)

  2. Functional reach test

    Time frame: Change from Baseline to 7 weeks

    Objective test that measures how far a person can reach with one arm in standing position. Unit: cm.

  3. Modified functional reach test

    Time frame: Change from Baseline to 7 weeks

    Objective test that measures how far a person can reach (forward, left, right) with one arm in sitting position. Unit: cm.

    NB: This test is used for wheel-chair users only.

  4. Four square step test (FSST)

    Time frame: Change from Baseline to 7 weeks

    Objective test that measures dynamic stability and co-ordination. Unit: s.

  5. 6-minute walk test

    Time frame: Change from Baseline to 7 weeks

    Objective test that measures walking endurance. Unit: meters.

  6. Trunk Impairment Scale 2.0

    Time frame: Change from Baseline to 7 weeks

    Rater-evaluated test that measures static and dynamic sitting balance as well as co-ordination of trunk movement. Unit: score (0-23; 23 is better).

    NB: This test is used for wheel-chair users only.

  7. Patient determined disease steps

    Time frame: Change from Baseline to 7 weeks

    Questionnaire that measures level of disability in multiple sclerosis. Unit: score (0-8; 0 is better).

  8. Multiple Sclerosis Walking Scale

    Time frame: Change from Baseline to 7 weeks

    Questionnaire that measures walking limitations in multiple sclerosis. Unit: score (0-100; 0 is better).

  9. Health-related quality of life visual analogue scale (HR-QoL VAS)

    Time frame: Change from Baseline to 7 weeks

    Questionnaire/scale that measures quality of life. Unit: score (0-100; 0 is better).

  10. Modified fatigue impact scale

    Time frame: Change from Baseline to 7 weeks

    Questionnaire that measures the impact fatigue has on daily life. Unit: score (0-84; 0 is better)

  11. Falls-efficacy scale - international

    Time frame: Change from Baseline to 7 weeks

    Questionnaire that measures concerns about falling. Unit: score (16-64; 16 is better)

  12. Falls

    Time frame: Change from Baseline to 7 weeks

    Number of falls in the past year

Sponsors and collaborators

Lead sponsor

University of Aarhus

Other

Collaborators

  • The Danish MS Society

Registry information

Official study title

MS Ballroom Fitness - Benefits of a Personalized Dance-based Concept on Balance, Walking Capacity, and Well-being in Multiple Sclerosis

Important dates

Study start
2023
Primary completion
2024
Study completion
2024
First posted
Sep 8, 2023
Registry last updated
Mar 19, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.